evidence table

Curcumin Cognition Randomized Trial Evidence Table

Structured evidence table for Curcumin Cognition Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.

topicclaimevidence levelcitationsource
Curcumin Cognition Randomized TrialDiscussion Overall, Zingiberaceae-derived interventions may improve memory-related outcomes, but the evidence is very uncertain due to substantial heterogeneity, the small number of studies, risk of bias in some trials, and variability in populations, formulations, and outcome measures.1Victoria-Montesinos D (2026)Effects of Zingiberaceae-derived interventions on memory-related and other cognitive outcomes in adults: a systematic review and meta-analysis.
Curcumin Cognition Randomized TrialIntroduction Cognitive impairment and age-related cognitive decline are major public health concerns, and nutraceutical strategies targeting modifiable biological pathways have attracted growing interest.1Victoria-Montesinos D (2026)Effects of Zingiberaceae-derived interventions on memory-related and other cognitive outcomes in adults: a systematic review and meta-analysis.
Curcumin Cognition Randomized TrialCompounds derived from the Zingiberaceae family, including curcumin, turmeric, ginger, and related preparations, have been investigated for their potential neuroprotective effects, but their clinical impact on specific cognitive domains remains unclear.1Victoria-Montesinos D (2026)Effects of Zingiberaceae-derived interventions on memory-related and other cognitive outcomes in adults: a systematic review and meta-analysis.
Curcumin Cognition Randomized TrialIn parallel, epidemiological evidence has consistently linked specific dietary patterns, such as the Mediterranean and MIND diets, to a reduced risk of cognitive decline and AD [].2Kumari Ankita (2026)Dietary Bioactives in Alzheimer’s Disease: A Critical Appraisal of Clinical Trials and Future Nutritional Strategies
Curcumin Cognition Randomized TrialThese changes progress to reduced brain volume and are responsible for the memory loss associated with AD [].2Kumari Ankita (2026)Dietary Bioactives in Alzheimer’s Disease: A Critical Appraisal of Clinical Trials and Future Nutritional Strategies
Curcumin Cognition Randomized TrialThis definition aligns with the Office of Dietary Supplements (NIH, Bethesda, MD, USA) framework, which characterizes bioactives as food or supplement constituents, excluding essential nutrients that influence cellular activities, metabolic pathways, or disease risk [].2Kumari Ankita (2026)Dietary Bioactives in Alzheimer’s Disease: A Critical Appraisal of Clinical Trials and Future Nutritional Strategies
Curcumin Cognition Randomized Trial1 2 The prevalence of Alzheimer’s disease (AD) is projected to escalate in line with rising life expectancies across various nations.2Kumari Ankita (2026)Dietary Bioactives in Alzheimer’s Disease: A Critical Appraisal of Clinical Trials and Future Nutritional Strategies
topicCurcumin Cognition Randomized Trial
claimDiscussion Overall, Zingiberaceae-derived interventions may improve memory-related outcomes, but the evidence is very uncertain due to substantial heterogeneity, the small number of studies, risk of bias in some trials, and variability in populations, formulations, and outcome measures.
evidence level1
citationVictoria-Montesinos D (2026)
sourceEffects of Zingiberaceae-derived interventions on memory-related and other cognitive outcomes in adults: a systematic review and meta-analysis.
topicCurcumin Cognition Randomized Trial
claimIntroduction Cognitive impairment and age-related cognitive decline are major public health concerns, and nutraceutical strategies targeting modifiable biological pathways have attracted growing interest.
evidence level1
citationVictoria-Montesinos D (2026)
sourceEffects of Zingiberaceae-derived interventions on memory-related and other cognitive outcomes in adults: a systematic review and meta-analysis.
topicCurcumin Cognition Randomized Trial
claimCompounds derived from the Zingiberaceae family, including curcumin, turmeric, ginger, and related preparations, have been investigated for their potential neuroprotective effects, but their clinical impact on specific cognitive domains remains unclear.
evidence level1
citationVictoria-Montesinos D (2026)
sourceEffects of Zingiberaceae-derived interventions on memory-related and other cognitive outcomes in adults: a systematic review and meta-analysis.
topicCurcumin Cognition Randomized Trial
claimIn parallel, epidemiological evidence has consistently linked specific dietary patterns, such as the Mediterranean and MIND diets, to a reduced risk of cognitive decline and AD [].
evidence level2
citationKumari Ankita (2026)
sourceDietary Bioactives in Alzheimer’s Disease: A Critical Appraisal of Clinical Trials and Future Nutritional Strategies
topicCurcumin Cognition Randomized Trial
claimThese changes progress to reduced brain volume and are responsible for the memory loss associated with AD [].
evidence level2
citationKumari Ankita (2026)
sourceDietary Bioactives in Alzheimer’s Disease: A Critical Appraisal of Clinical Trials and Future Nutritional Strategies
topicCurcumin Cognition Randomized Trial
claimThis definition aligns with the Office of Dietary Supplements (NIH, Bethesda, MD, USA) framework, which characterizes bioactives as food or supplement constituents, excluding essential nutrients that influence cellular activities, metabolic pathways, or disease risk [].
evidence level2
citationKumari Ankita (2026)
sourceDietary Bioactives in Alzheimer’s Disease: A Critical Appraisal of Clinical Trials and Future Nutritional Strategies
topicCurcumin Cognition Randomized Trial
claim1 2 The prevalence of Alzheimer’s disease (AD) is projected to escalate in line with rising life expectancies across various nations.
evidence level2
citationKumari Ankita (2026)
sourceDietary Bioactives in Alzheimer’s Disease: A Critical Appraisal of Clinical Trials and Future Nutritional Strategies

Learn next

Related evidence and supplement guides

SupplementCurcumin (Turmeric)Turmeric's active compound with potent anti-inflammatory properties — bioavailability is the cri...GuideCurcumin Cognition Randomized Trial: What the Evidence SaysCurcumin Cognition Randomized Trial has 2 source documents in the current Migaku evidence databa...GuideGrape Seed Cognition Randomized Trial: What the Evidence SaysGrape Seed Cognition Randomized Trial has 2 source documents in the current Migaku evidence data...GuideZeaxanthin Cognition Randomized Trial: What the Evidence SaysZeaxanthin Cognition Randomized Trial has 2 source documents in the current Migaku evidence data...GuideMethylfolate Cognition Randomized Trial: What the Evidence SaysMethylfolate Cognition Randomized Trial has 2 source documents in the current Migaku evidence da...CompareCurcumin BCM95 vs Curcumin Standard ExtractBCM95 is a patented curcumin with superior bioavailability compared to standard curcumin extract...RankingBest Nootropics for Focus & Attention: 2026 Clinical Evidence ReviewWe separate the clinical evidence from the marketing hype, ranking the most effective brain supp...RankingBest Supplements for Anxiety: Evidence-Based Rankings 2026Anxiety supplements with genuine clinical evidence include ashwagandha (strongest for chronic an...

Source documents

  1. Effects of Zingiberaceae-derived interventions on memory-related and other cognitive outcomes in adults: a systematic review and meta-analysis.
  2. Dietary Bioactives in Alzheimer’s Disease: A Critical Appraisal of Clinical Trials and Future Nutritional Strategies